The pharmacokinetics of pranlukast in healthy young and elderly subjects

Pranlukast is a novel LTD4 antagonist under development for the treatment of asthma. To assess the effect of age, the pharmacokinetics of pranlukast were studied in healthy young (9 females, 10 males, mean 30 years) and elderly subjects (9 per sex, mean 70.4 years). After an overnight fast volunteer...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of clinical pharmacology and therapeutics Vol. 34; no. 9; p. 375
Main Authors Brocks, D R, Upward, J, Hust, R, Köester, F E, Collie, H, Qian, Y, Dennis, M J
Format Journal Article
LanguageEnglish
Published Germany 01.09.1996
Subjects
Online AccessGet more information

Cover

Loading…